EYE-GO A/S’ Post

Study Results: MistGo® Sets a New Standard in Eye Care The results are in! EYE-GO’s recent study involving 22 patients with glaucoma or high eye pressure over 14 days highlights the transformative impact of MistGo® on eye medication delivery. Here’s what we learned: Key findings: 1. Exceptional User-Friendliness: Patients rated MistGo® 9.4/10 for ease of use, compared to 6.6/10 for traditional eye drops. “It was just…puff and done. Incredibly simple to use” 2. Superior Comfort: MistGo® achieved a 9.5/10 comfort rating, surpassing traditional eye drops at 7.2/10. “There was no discomfort at all. Much more comfortable to eye drops”. 3. Minimal Waste, Maximum Precision: Patients reported being significantly less bothered by excess liquid, with MistGo® scoring 9.9/10 vs 5.8/10 for traditional eye drops. 4. Overwhelming Preference: 20 of 22 participants indicated a preference for MistGo® over traditional eye drops. “This will help a lot of people! When will it be on the market?” What’s next? EYE-GO is eager to bring these results to life. If you’re an investor or ophthalmology player passionate about transforming patient outcomes, let’s connect! #EYEGO #MISTGO #Ophthalmology #StudyResults

  • graphical user interface, application
Henrik Nagel

Chief Executive Officer @ EYE-GO A/S | Board member | Advisor

3w

We truly has the best next generation delivery system regarding adherence and compliance

Nazarena Mazzaro

VP Global R&D - Board Member

2w

Hope it comes to the market fast. Patients that depend on eye medication needs this technology.

Ralf Gergen

PASSIONATE EBIKE ENTHUSIAST | SEALING EXPERT

3w

I'm glad to hear that. I wish you a successful launch. It's about people and health. Every innovation that brings about an improvement in the treatment of diseases is important. Thank you for this good news.

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics